Award
Delivery Order #SPE2DR26FAVMQ
AmerisourceBergen Delivery Order for Atrovent HFA Inhaler
Buyer
Defense Logistics Agency
Award Amount
$3,511.82
Ceiling
$3,511.82
Awarded
February 20, 2026
Period of Performance
Feb 20, 2026 – Feb 23, 2026
Identifier
SPE2DR26FAVMQ
NAICS
325411
This contract is a delivery order issued under a broader indefinite delivery vehicle (IDV) previously awarded to AmerisourceBergen Drug Corp, a leading pharmaceutical services provider specializing in drug distribution and healthcare logistics. The delivery order procures a specific pharmaceutical product, the Atrovent HFA inhaler, used for respiratory treatments. This procurement supports ongoing healthcare and treatment needs, ensuring timely availability of critical medicines. The contract covers the supply and delivery of this medicine within a short, defined timeframe at the designated location in Conshohocken, Pennsylvania. The award builds upon AmerisourceBergen’s established role in pharmaceutical supply chains under the existing multi-year European procurement IDV, emphasizing the company’s capability in fulfilling both routine and specialized drug orders. The contract was awarded through a delivery order mechanism, likely leveraging competitive or pre-established agreements under the IDV. The delivery order marks a focused, short-term procurement commitment within the larger framework of AmerisourceBergen’s long-term government supply contracts.
Description
4570894590!ATROVENT HFA 12.9GM 1S